It’s been anything but easy run for the makers of Xarelto. There has been a slew of lawsuits alleging that drug is responsible for patients uncontrollable bleedouts.
The lawsuits against the makers of Xarelto are claiming that the companies, pharmaceutical giants Bayer and Johnson & Johnson, failed to adequately warn consumers of the risks of Xarelto and published misleading advertising over stating the drugs benefits. Plaintiffs also argue that the drug was not properly tested before hitting the market in 2011 and should not have been approved without an antidote.
The US Judicial Panel on Multidistrict Litigation has decided to consolidate the Xarelto lawsuits in a Louisiana federal court. What this means is that the cases will be tried together as one case rather than each case having to be filed separately in the district courts. This is a great thing for the consumers and not good for the manufacturers of the drug.
